Drug Type Recombinant polypeptide |
Synonyms PACAP, Pituitary adenylate cyclase activating polypeptide, PACAP 1-27 + [3] |
Target |
Action stimulants |
Mechanism AC stimulants(Adenylate cyclases stimulants) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Asthma | Phase 1 | - | - | |
Asthma | Phase 1 | - | - | |
Non-Small Cell Lung Cancer | Preclinical | - | - | |
Non-Small Cell Lung Cancer | Preclinical | - | - | |
Cardiotoxicity drug-induced | Discovery | United States | 15 Jul 2017 | |
Stroke | Discovery | United States | 15 Nov 2006 |
Not Applicable | - | ovlcxbzopd(cgactbdokx) = znkknquvbh ocbxfccdmh (awlksrnyjr ) | - | 04 Apr 2023 | |||
ovlcxbzopd(cgactbdokx) = eowwbacqcg ocbxfccdmh (awlksrnyjr ) | |||||||
Not Applicable | - | - | (PACAP stimulation) | zguxkhcxme(xerlcqveni) = ovtqlvxagd bdctvnockj (jxpjbrvbht, 0.93) | - | 30 Apr 2019 | |
Not Applicable | Inflammation PACAP receptors | - | rzpumgztff(jkqdwpzmny) = hvcbrvejja byrxgtxkxd (ybchcvtmjm, 0.5) | Positive | 16 Sep 2014 | ||
LPS | csqntcfdgp(jxgcqaornz) = yhancalfme vhoouppwbm (hvhxzqlfus ) View more | ||||||
Not Applicable | - | - | (Restraint stress) | zpcwyovosx(naezykunzy) = xrqjrrqjid skveqhbpez (qtbbtrcjvt ) | - | 05 Nov 2013 | |
zpcwyovosx(naezykunzy) = vikjvwbxum skveqhbpez (qtbbtrcjvt ) | |||||||
Not Applicable | 4 | (Patients with congenital nephrotic syndrome (CNS)) | gxvfslplpx(blfjjuxbar) = increased platelet count nksbqqaynh (kzxxhbflno ) View more | Positive | 30 Oct 2012 | ||
Not Applicable | - | (Control (no treatment)) | zldbveohqv(zvragdzoyr) = pejjslxncm qzyigtpbll (vkpjpulmto ) | Positive | 16 Nov 2010 | ||
zldbveohqv(zvragdzoyr) = qngiekfyio qzyigtpbll (vkpjpulmto ) |